MetLife (MET) Faces Q2 Valuation Questions, Is The Stock Fully Priced?

MetLife preferred dividend declaration and what it means for investors

MetLife (MET) declared a fresh set of preferred stock dividends for the third quarter of 2026, a routine capital allocation move that gives investors more detail on the company’s funding and payout structure.

The board approved payments on several non cumulative preferred series, with different coupon structures and liquidation preferences that appeal to distinct investor income needs. These dividends are scheduled to be paid on September 15, 2026, to shareholders of record on August 31, 2026.

See our latest analysis for MetLife.

MetLife’s preferred dividend declaration comes shortly after its Q2 results, where revenue growth coincided with book value per share coming in below analyst expectations, and against a sector backdrop shaped by rising interest rates and competition from insurtech firms. The stock’s recent 0.94% 1 day share price return contrasts with a 3.40% decline over seven days, while a 17.46% year to date share price return and 5 year total shareholder return of 74.70% indicate momentum that has built over a longer horizon.

If this kind of income and insurance exposure is on your radar, it can be useful to see what else is moving in related areas and beyond. A good next step is to scan 21 top founder-led companies

MetLife’s recent mix of solid long term returns and a softer reaction to Q2 book value has left investors weighing fundamentals against sentiment. How does that trade off look when it is lined up against today’s valuation?

Preferred multiple of 17.4x P/E on MetLife: Is it justified?

On the latest numbers, MetLife trades on a P/E of 17.4x, which screens as expensive relative to several reference points, even though the SWS DCF model suggests the stock is trading at a discount to its own cash flow based fair value.

The P/E multiple compares the current share price to the company’s earnings per share. For an insurer such as MetLife, it is a simple way for investors to see how much they are paying for each dollar of earnings and to compare that with peers and historical ranges.

Here, the SWS checks flag that MetLife’s 17.4x P/E is higher than the US Insurance industry average of 11.2x, higher than the peer average of 14.4x, and above the estimated fair P/E of 16x that the fair ratio model points to as a level the market could move towards if pricing became more in line with fundamentals. That suggests investors are currently paying a premium for MetLife’s earnings compared with sector benchmarks, even though the stock is assessed as trading 44.3% below an internal estimate of fair value based on future cash flows.

Explore the SWS fair ratio for MetLife

Result: Price-to-earnings of 17.4x (OVERVALUED)

However, investors still need to watch for pressure on MetLife’s US insurance peers that could weigh on sector valuations, as well as any shift in the discount to analyst targets.

Find out about the key risks to this MetLife narrative.

Another view on MetLife’s valuation

While the 17.4x P/E suggests MetLife is priced richly against insurance peers, the SWS DCF model paints a different picture. On that measure, the stock trades 44.3% below an estimate of its future cash flow value of $169.28. Which signal matters more for you: earnings multiple or cash flow gap?

For investors who want to see how this cash flow view is built line by line, and where the key assumptions sit, Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out MetLife for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 48 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With MetLife showing both potential rewards and flagged risks, it can be helpful to move quickly and review the underlying data yourself. To examine that balance in more detail, start with the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond MetLife?

If MetLife has your attention, do not stop there. Broadening your watchlist now can help you spot opportunities that others may only notice much later.

• Target quality at a discount by checking out companies that screen as attractively priced with solid fundamentals through the 48 high quality undervalued stocks.
• Build a steadier income base by focusing on companies with robust yields and consistent payout histories using the 12 dividend fortresses.
• Strengthen your downside protection by filtering for companies with resilient finances in the 78 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com